CA
EVH icon

CoreCap Advisors’s Evolent Health EVH Stock Holding History

CoreCap Advisors’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-39
Closed -$211 – 3228
2026
Q2 		$211 Hold
39
– – ﹤0.01% 2998
2026
Q1 		$89 Hold
39
– – ﹤0.01% 2847
2025
Q4 		$156 Buy
+39
New +$217 ﹤0.01% 2836

Other funds holding EVH

CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

CoreCap Advisors's EVH Position: Q3 2026 in Review

CoreCap Advisors sold out of Evolent Health (EVH) in Q3 2026, closing a stake of 39 shares — an estimated $211 sold.

CoreCap Advisors first reported a position in EVH in Q4 2025 and held it in 3 quarters. The position peaked at $211 in Q2 2026. 4 funds tracked by Wall St. Rank hold EVH as of Q3 2026.

  • CoreCap Advisors reported no remaining Evolent Health position as of Q3 2026 after selling out during the quarter.
  • CoreCap Advisors sold 39 Evolent Health shares in Q3 2026, an estimated $211.
  • CoreCap Advisors first reported a position in Evolent Health in Q4 2025 and held it in 3 quarters.
  • CoreCap Advisors's Evolent Health position peaked at $211 in Q2 2026.
  • 4 funds tracked by Wall St. Rank held Evolent Health as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.